Goldstein: Expect More Litigation After Myriad

June 13 (Bloomberg Law) -- Tom Goldstein, partner at Goldstein & Russell, PC and founder of SCOTUSblog, talks with Bloomberg Law's Lee Pacchia about the United States Supreme Court's decision in the Association for Molecular Pathology v. Myriad Genetics, Inc. case. At issue was whether patents may be granted on parts of the human body. He also explores whether Justice Scalia's concurrence raises doubts whether he believes in molecular biology, and where patent litigation will head in the wake of the decision. Bloomberg Law is a sponsor of SCOTUSblog.
The Top Stocks to Watch in Asia Today
57:15 - In today’s “Stock Exchange,” Bloomberg’s Yvonne Man and Shery Ahn discuss the top stocks to watch in Asia on “First Up.” (Source: Bloomberg)
  • Japanese Market Is Showing Signs of Life: Dagan
  • Hanergy's Li Increased Short Position Before Stock Crash
  • Greece Calls on Creditors to Compromise